WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007005940) COMBINATIONS OF ESZOPICLONE AND DIDESMETHYLSIBUTRAMINE, AND METHODS OF TREATMENT OF MENOPAUSE AND MOOD, ANXIETY, AND COGNITIVE DISORDERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/005940    International Application No.:    PCT/US2006/026146
Publication Date: 11.01.2007 International Filing Date: 05.07.2006
IPC:
A01N 43/58 (2006.01), A01N 43/60 (2006.01), A61K 31/495 (2006.01), A61K 31/50 (2006.01)
Applicants: SEPRACOR INC. [US/US]; 84 Waterford Drive, Marlborough, Massachusetts 01752 (US) (For All Designated States Except US).
CARON, Judy [US/US]; (US) (For US Only).
WESSEL, Thomas [US/US]; (US) (For US Only).
LALJI, Karim [US/US]; (US) (For US Only).
VARNEY, Mark A. [US/US]; (US) (For US Only)
Inventors: CARON, Judy; (US).
WESSEL, Thomas; (US).
LALJI, Karim; (US).
VARNEY, Mark A.; (US)
Agent: TIMMER, Edward; HESLIN ROTHENBERG FARLEY & MESITI P.C., 5 Columbia Circle, Albany, New York 12203 (US)
Priority Data:
60/696,880 06.07.2005 US
Title (EN) COMBINATIONS OF ESZOPICLONE AND DIDESMETHYLSIBUTRAMINE, AND METHODS OF TREATMENT OF MENOPAUSE AND MOOD, ANXIETY, AND COGNITIVE DISORDERS
(FR) COMBINAISONS D'ESZOPICLONE ET DE DIDESMETHYLSIBUTRAMINE, METHODES DE TRAITEMENT DE LA MENOPAUSE, DE L'HUMEUR, DE L'ANXIETE ET DES TROUBLES DE LA CONNAISSANCE
Abstract: front page image
(EN)One aspect of the present invention relates to pharmaceutical compositions containing two or more active agents that when taken together can be used to treat, e.g., menopause, mood disorders, anxiety disorders, or cognitive disorders. The first component of the pharmaceutical composition is a sedative eszopiclone. The second component of the pharmaceutical composition is didesmethylsibutramine or (S)-didesmethylsibutramine. The present invention also relates to a method of treating menopause, perimenopause, mood disorders, anxiety disorders, and cognitive disorders.
(FR)Un aspect de la présente invention concerne des compositions pharmaceutiques contenant au moins deux agents actifs qui, lorsqu'ils sont pris ensemble, peuvent être utilisés pour traiter, par exemple, la ménopause, les troubles de l'humeur, les troubles anxieux ou les troubles de la connaissance. Le premier constituant de la composition pharmaceutique est un eszopiclone sédatif. Le deuxième constituant de la composition pharmaceutique est la didesméthylsibutramine ou (S)-didesméthylsibutramine. Cette invention porte également sur une méthode de traitement de la ménopause, de la périménopause, des troubles de l'humeur, des troubles anxieux et des troubles de la connaissance.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)